Latest Breaking News On - Daniele geffken - Page 1 : comparemela.com

Eloxx Pharmaceuticals (NASDAQ:ELOX) Price Target Cut to $3 00 by Analysts at B Riley

Eloxx Pharmaceuticals (NASDAQ:ELOX) Price Target Cut to $3 00 by Analysts at B Riley
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Thomson reuterDaniele geffkenGeode capital managementAnalyst recommendations for eloxx pharmaceuticalsEloxx pharmaceuticalsZacks investment researchDeutsche bankEloxx pharmaceuticals incVanguard group incTopco ltdEloxx pharmaceuticals company profileInvestment researchCapital management

Zacks Investment Research Upgrades Eloxx Pharmaceuticals (NASDAQ:ELOX) to Buy

Zacks Investment Research Upgrades Eloxx Pharmaceuticals (NASDAQ:ELOX) to Buy
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United statesThomson reuterDaniele geffkenSecurities exchange commissionAnalyst recommendations for eloxx pharmaceuticalsEloxx pharmaceuticalsZacks investment researchEloxx pharmaceuticals incVanguard group incNantahala capital managementEloxx pharmaceuticals company profileSevion therapeutics incExchange commissionCapital wealth advisorsCapital managementMarket capitalization